Literature DB >> 16061381

The status of neck node metastases in breast cancer--loco-regional or distant?

A M Sesterhenn1, U S Albert, P J Barth, U Wagner, J A Werner.   

Abstract

Metastases to cervical lymph nodes do not exclusively derive from malignancies of the head and neck area. In the literature the region where distant metastases of breast carcinomas to the neck occur is exclusively named "supraclavicular". The system established by head and neck surgeons regarding neck node topography allows interdisciplinary management of patients with cervical lymph node metastases from breast cancer. Twelve patients suffering from breast cancer who presented with cervical masses have been examined. Most lymph node metastases were found in the posterior triangle of the neck and at the caudo-jugular level, but some metastases were even found in the upper jugular levels. The results presented show that neck node metastases of breast cancer are located superiorly to the supraclavicular region in more than 50% of the cases. According to the AJCC Staging System for Breast Cancer metastases located in the supraclavicular fossa are assessed as loco-regional metastases (N3c). Lymph node metastases situated above the supraclavicular region are not mentioned, but should be considered as distant metastases. This important question remains unanswered and deserves clarification in the current classification of the AJCC Staging System for Breast Cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16061381     DOI: 10.1016/j.breast.2005.05.006

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  9 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

2.  Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma.

Authors:  Andreas Nauroth; Matthias Kalder; Marion Rössler; Gunnar Wichmann; Andreas Dietz; Susanne Wiegand
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-20       Impact factor: 4.553

3.  Breast cancer combined with contralateral neck lymph node metastasis: a case report.

Authors:  Xiaoxiao Zhong; Fengjiao Ding; Liyuan Qian; Wei Wu; Yanguang Wen; Boni Ding
Journal:  Diagn Pathol       Date:  2022-07-15       Impact factor: 3.196

4.  Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement.

Authors:  Tianyi Ma; Yan Mao; Haibo Wang
Journal:  Cancer Manag Res       Date:  2020-11-19       Impact factor: 3.989

5.  Stridor as the First Presentation of Metastatic Breast Cancer that Was Managed with Chemotherapy: a Case Report.

Authors:  Ashraf Khater; Adel El-Badrawy; Mohamed Awad Ebrahem
Journal:  Indian J Surg Oncol       Date:  2018-01-25

6.  Treatment and prognosis for retrograde cervical lymph node metastases in breast cancer.

Authors:  Rong Qin; Qiaoyu Zhang; Jianfeng Weng; Weiping Liu; Bo Zhang; Gang Lv; Yi Wang; Youjun Wu; Yongdong Pu
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13

7.  Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report.

Authors:  Victor Manuel Saure Sarría; Ariel D Arencibia; Vívian D'Afonseca
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

8.  Survey of UK practice for management of breast cancer metastases to the neck.

Authors:  B Bisase; C Kerawala
Journal:  Ann R Coll Surg Engl       Date:  2012-10       Impact factor: 1.891

9.  Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02).

Authors:  Jae Sik Kim; Kyubo Kim; Kyung Hwan Shin; Jin Ho Kim; Seung Do Ahn; Su Ssan Kim; Yong Bae Kim; Jee Suk Chang; Doo Ho Choi; Won Park; Tae Hyun Kim; Mison Chun; Jihye Cha; Jin Hee Kim; Dong Soo Lee; Sun Young Lee; Hae Jin Park
Journal:  J Breast Cancer       Date:  2020-02-13       Impact factor: 3.588

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.